• Licensing the patented production process from Genomatica;
• Targeting large scale commercial production of renewable butanediol;
• Further enhancing BASF’s portfolio with a renewable-based product.
The one-step fermentation process is based on sugars as a renewable feedstock. The companies have agreed not to disclose financial details of the agreement.
The license agreement allows BASF to build a world-scale production facility that will use the Genomatica process to manufacture BDO based on renewable feedstock. Under the terms of the agreement, Genomatica will continue to advance its patented renewable BDO production process technology based on sugars while BASF will produce renewable BDO, which will be available in the second half of 2013 for sampling and trials.
“We chose the Genomatica process because we consider it to be exceptionally advanced and reliable,” said Sanjeev Gandhi, President of BASF Intermediates division, and added: “In line with our ‘We create chemistry’ strategy, we aim to offer renewable BDO and create additional value for our customers, in the plastics, textile and automotive industries.”
“We are pleased to cooperate with BASF, the leading global BDO manufacturer with a worldwide manufacturing and sales network and many years of market experience,” said Christophe Schilling, Chief Executive Officer of Genomatica, and continued: “This agreement highlights Genomatica’s commitment to delivering innovative process technologies to the global chemical industry.”
BDO and its derivatives are widely used for producing plastics, solvents, electronic chemicals and elastic fibers. The starting materials for the production of conventional BDO are natural gas, butane, butadiene and propylene. BASF currently produces BDO and BDO-equivalents at its sites in Ludwigshafen, Germany; Geismar, Louisiana; Chiba, Japan; Kuantan, Malaysia; and Caojing, China, and has an annual capacity of 535,000 metric tons. BASF has recently announced the intention of building a BDO complex in China with a capacity of 100,000 annual metric tons.
Genomatica is a technology leader for the chemical industry. It delivers new manufacturing processes that enable its partners to produce intermediate and basic chemicals from renewable feedstocks. These chemicals serve as the basis for making substantially all of the products that make modern life possible. Genomatica is developing a pipeline of manufacturing processes for the production of these chemicals, including BDO and butadiene, as well as other targets.
BASF (basf.com) is the world’s leading chemical company: The Chemical Company. Its portfolio ranges from chemicals, plastics, performance products and crop protection products to oil and gas. We combine economic success with environmental protection and social responsibility. Through science and innovation, we enable our customers in nearly every industry to meet the current and future needs of society. Our products and solutions contribute to conserving resources, ensuring nutrition and improving quality of life. We have summed up this contribution in our corporate purpose: We create chemistry for a sustainable future. BASF had sales of €72.1 billion in 2012 and more than 110,000 employees as of the end of the year. BASF shares are traded on the stock exchanges in Frankfurt (BAS), London (BFA) and Zurich (AN).
About BASF Intermediates
The BASF Group’s Intermediates (intermediates.basf.com) division develops, produces and markets a comprehensive portfolio of more than 600 intermediates around the world. The most important of the division’s product groups include amines, diols, polyalcohols, acids and specialties. Among other applications, intermediates are used as starting materials for coatings, plastics, pharmaceuticals, textile fibers, detergents and crop protectants. Innovative intermediates from BASF help to improve the properties of final products and the efficiency of production processes. The ISO 9001 certified Intermediates division operates plants at production sites in Europe, Asia, and the Americas. Around the globe the division generated sales to third parties of about €2.9 billion in 2012.
Contact: Ilene Adler, Genomatica
P: 415.984.1970 x0102 - E: media[.]genomatica.com.